Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
ADMA Biologics, Inc. (NASDAQ: ADMA)
ADMA Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
28.10%
Analyst Rating:
BUY
Analyst Forecast (1yr):
22.40%
ADMA Stock Analysis
ADMA
PE Ratio:
11.4
ADMA
PEG Ratio:
0.6
ADMA
Forward EPS Growth (12 month):
19.90%
ADMA
PS Ratio:
3.5
ADMA
PSG Ratio:
0.2
ADMA
Forward Revenue Growth (12 month):
14.90%
ADMA Articles
No data was found